Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
N4 Pharma Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
N4 Pharma has a total shareholder equity of £1.3M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £1.3M and £56.0K respectively.
Anahtar bilgiler
0%
Borç/özkaynak oranı
UK£0
Borç
| Faiz karşılama oranı | n/a |
| Nakit | UK£1.20m |
| Eşitlik | UK£1.28m |
| Toplam yükümlülükler | UK£56.04k |
| Toplam varlıklar | UK£1.34m |
Son finansal sağlık güncellemeleri
Companies Like N4 Pharma (LON:N4P) Are In A Position To Invest In Growth
Oct 11
Here's Why We're Not Too Worried About N4 Pharma's (LON:N4P) Cash Burn Situation
Jul 06Companies Like N4 Pharma (LON:N4P) Can Afford To Invest In Growth
Dec 07
Recent updates
Companies Like N4 Pharma (LON:N4P) Are In A Position To Invest In Growth
Oct 11Here's Why We're Not Too Worried About N4 Pharma's (LON:N4P) Cash Burn Situation
Jul 06Should Shareholders Have Second Thoughts About A Pay Rise For N4 Pharma Plc's (LON:N4P) CEO This Year?
Mar 18Here's What We Think About N4 Pharma's (LON:N4P) CEO Pay
Mar 01Companies Like N4 Pharma (LON:N4P) Can Afford To Invest In Growth
Dec 07Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: N4P's short term assets (£1.3M) exceed its short term liabilities (£56.0K).
Uzun Vadeli Yükümlülükler: N4P has no long term liabilities.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: N4P is debt free.
Borcun Azaltılması: N4P had no debt 5 years ago.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: N4P has sufficient cash runway for more than a year based on its current free cash flow.
Tahmini Nakit Akışı: N4P has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 0.5% each year.